BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17354256)

  • 1. Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma.
    Görögh T; Weise JB; Holtmeier C; Rudolph P; Hedderich J; Gottschlich S; Hoffmann M; Ambrosch P; Csiszar K
    J Pathol; 2007 May; 212(1):74-82. PubMed ID: 17354256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer.
    Weise JB; Csiszar K; Gottschlich S; Hoffmann M; Schmidt A; Weingartz U; Adamzik I; Heiser A; Kabelitz D; Ambrosch P; Görögh T
    Int J Oncol; 2008 Feb; 32(2):317-22. PubMed ID: 18202753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas.
    Holtmeier C; Görögh T; Beier U; Meyer J; Hoffmann M; Gottschlich S; Heidorn K; Ambrosch P; Maune S
    Anticancer Res; 2003; 23(3B):2585-91. PubMed ID: 12894545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOXL4 as a selective molecular marker in primary and metastatic head/neck carcinoma.
    Scola N; Görögh T
    Anticancer Res; 2010 Nov; 30(11):4567-71. PubMed ID: 21115907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
    Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts.
    Görögh T; Quabius ES; Heidebrecht H; Nagy A; Muffels T; Haag J; Ambrosch P; Hoffmann M
    Int J Cancer; 2016 May; 138(10):2529-38. PubMed ID: 26756583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the 5' flanking domain of the LOXL4 gene in head and neck squamous cell carcinoma cells.
    Görögh T; Holtmeier C; Weise JB; Hoffmann M; Ambrosch P; Laudien M; Csiszar K
    Int J Oncol; 2008 Nov; 33(5):1091-8. PubMed ID: 18949373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
    Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
    Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells.
    Kim DJ; Lee DC; Yang SJ; Lee JJ; Bae EM; Kim DM; Min SH; Kim SJ; Kang DC; Sang BC; Myung PK; Park KC; Yeom YI
    Biochem Biophys Res Commun; 2008 Sep; 373(4):521-7. PubMed ID: 18586005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.
    Secades P; Rodrigo JP; Hermsen M; Alvarez C; Suarez C; Chiara MD
    Genes Chromosomes Cancer; 2009 May; 48(5):441-54. PubMed ID: 19235921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
    Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
    J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.
    Woenckhaus J; Steger K; Werner E; Fenic I; Gamerdinger U; Dreyer T; Stahl U
    J Pathol; 2002 Nov; 198(3):335-42. PubMed ID: 12375266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
    Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
    Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer.
    Weise JB; Rudolph P; Heiser A; Kruse ML; Hedderich J; Cordes C; Hoffmann M; Brant O; Ambrosch P; Csiszar K; Görögh T
    Eur J Cancer; 2008 Jun; 44(9):1323-31. PubMed ID: 18499440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of p68 mRNA in head and neck squamous cell carcinoma cells.
    Beier UH; Maune S; Meyer JE; Görögh T
    Anticancer Res; 2006; 26(3A):1941-6. PubMed ID: 16827128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.
    Wang MB; Alavi S; Engstrom M; Lee J; Namazie A; Moatamed F; Srivatsan ES
    Anticancer Res; 1999; 19(2A):925-31. PubMed ID: 10368635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.